These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Structural Insight into Nucleoprotein Conformation Change Chaperoned by VP35 Peptide in Marburg Virus. Liu B; Dong S; Li G; Wang W; Liu X; Wang Y; Yang C; Rao Z; Guo Y J Virol; 2017 Aug; 91(16):. PubMed ID: 28566377 [TBL] [Abstract][Full Text] [Related]
13. Filovirus proteins for antiviral drug discovery: Structure/function bases of the replication cycle. Martin B; Canard B; Decroly E Antiviral Res; 2017 May; 141():48-61. PubMed ID: 28192094 [TBL] [Abstract][Full Text] [Related]
14. Insights into Ebola Virus VP35 and VP24 Interferon Inhibitory Functions and their Initial Exploitation as Drug Targets. Fanunza E; Frau A; Corona A; Tramontano E Infect Disord Drug Targets; 2019; 19(4):362-374. PubMed ID: 30468131 [TBL] [Abstract][Full Text] [Related]
15. Identification of Myricetin as an Ebola Virus VP35-Double-Stranded RNA Interaction Inhibitor through a Novel Fluorescence-Based Assay. Daino GL; Frau A; Sanna C; Rigano D; Distinto S; Madau V; Esposito F; Fanunza E; Bianco G; Taglialatela-Scafati O; Zinzula L; Maccioni E; Corona A; Tramontano E Biochemistry; 2018 Nov; 57(44):6367-6378. PubMed ID: 30298725 [TBL] [Abstract][Full Text] [Related]
20. High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system. Lee N; Shum D; König A; Kim H; Heo J; Min S; Lee J; Ko Y; Choi I; Lee H; Radu C; Hoenen T; Min JY; Windisch MP Antiviral Res; 2018 Oct; 158():226-237. PubMed ID: 30149038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]